Menu
Not yet recruiting NCT07746674

Central Line-Associated Bloodstream Infection QI Project

— Observational Central Line-associated Bloodstream Infection (CLABSI)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Central Line-associated Bloodstream Infection (CLABSI). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Central Line-Associated Bloodstream Infection (CLABSI) Quality Improvement Project

Overview

This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.

Primary outcome measures

  • Total number of central line days without a documented indication [Time frame: Up to Month 3]
Secondary outcome measures (2)
  • Number of femoral central lines in place for more than 2 days [Time frame: Up to Month 3]
  • Number of non-tunneled hemodialysis catheters without an active hemodialysis or continuous renal replacement therapy order [Time frame: Up to Month 3]

Eligibility criteria

Inclusion criteria

  • Not hospice patient class
  • Active central line for at least 24 hours

Exclusion criteria

  • No active central line
  • Central line present for less than 24 hours

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • NYU Langone Health — New York

Identifiers

NCT: NCT07746674 · QI-CLABSI

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗